BEAM vs CFLT · rev $63.5M vs rev $963.6M
Beam Therapeutics Inc (BEAM) versus Confluent Inc (CFLT) — a side-by-side from cached financials, not a winner call.
Beam Therapeutics Inc (BEAM) is a biotechnology company listed on US.
Confluent Inc (CFLT) is a software - infrastructure company listed on US.
Latest reported BEAM revenue for 2024-12-31 was $63.5M. Net income was -$376.7M. Revenue was down 83.2% from 2023-12-31 to 2024-12-31. BEAM currently screens at market cap $2.01B.
Latest reported CFLT revenue for 2024-12-31 was $963.6M. Net income was -$345.1M. Revenue was up 24.0% from 2023-12-31 to 2024-12-31. CFLT currently screens at market cap $11.13B.
BEAM currently screens at market cap $2.01B. CFLT currently screens at market cap $11.13B.
Not investment advice. Open the BEAM and CFLT stock pages for the full models.
Not investment advice.